Research-Grade Proteins

A Global Strategic Business Report

MCP32797

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7143

EXECUTIVE POOL

5850

PRICE

812

EXPERT INPUTS

34

COMPANIES

116

DATA TABLES

180

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Research-Grade Proteins Market to Reach US$2.0 Billion by 2030

The global market for Research-Grade Proteins estimated at US$1.0 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 12.4% over the analysis period 2024-2030. Cytokines & Growth Factors, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$683.0 Million by the end of the analysis period. Growth in the Antibodies segment is estimated at 9.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$265.7 Million While China is Forecast to Grow at 11.6% CAGR

The Research-Grade Proteins market in the U.S. is estimated at US$265.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.7% and 10.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Global Research-Grade Proteins Market – Key Trends & Drivers Summarized

Why Are Research-Grade Proteins Essential in Scientific and Biopharmaceutical Advancements?

Research-grade proteins play a fundamental role in biotechnology, pharmaceutical research, and life sciences, serving as key components in drug development, molecular biology, and diagnostic applications. These highly purified proteins are used extensively in academic and commercial research labs for studying protein functions, interactions, and structures. The increasing focus on precision medicine and biologic drug discovery has driven demand for research-grade proteins, particularly in proteomics, cell culture studies, and enzyme-linked immunosorbent assays (ELISAs). With the rise of recombinant protein production and advancements in protein engineering, researchers now have access to more stable, scalable, and high-quality proteins for experimental use. The ongoing expansion of the biopharmaceutical sector and growing investments in research and development (R&D) have further propelled the need for reliable, research-grade protein solutions.

How Are Technological Innovations Enhancing Research-Grade Protein Production?

The development of recombinant DNA technology has significantly improved the production of research-grade proteins, enabling scientists to express and purify proteins in microbial, mammalian, and insect cell systems with high yield and specificity. The integration of CRISPR-based genome editing techniques has also enhanced protein expression and functionality, providing researchers with precise tools to study gene regulation and protein interactions. Additionally, advancements in protein purification methods, such as affinity chromatography and mass spectrometry-based characterization, have improved the consistency and reproducibility of research-grade protein products. The adoption of artificial intelligence (AI) and computational biology in protein design is further accelerating protein engineering, allowing for the development of novel protein variants with enhanced stability and therapeutic potential. These innovations are ensuring that research-grade proteins meet the stringent quality and purity requirements of modern scientific applications.

What Market Trends Are Driving the Demand for Research-Grade Proteins?

The increasing use of protein-based assays in drug screening and biomarker discovery has been a significant factor driving the demand for research-grade proteins. The expansion of personalized medicine and the growing interest in cell and gene therapies have further fueled the need for high-quality protein reagents in research. Additionally, the rise of high-throughput screening techniques and automation in life sciences laboratories has created a demand for standardized, reproducible protein products. Pharmaceutical companies and contract research organizations (CROs) are investing heavily in research-grade proteins to accelerate drug discovery pipelines, particularly for monoclonal antibodies and recombinant biologics. The increasing availability of custom protein expression and purification services is also expanding the market, allowing researchers to access specialized proteins tailored to their experimental needs.

What Are the Key Growth Drivers of the Research-Grade Proteins Market?

The growth in the global research-grade proteins market is driven by increasing R&D investments in biopharmaceuticals, advancements in protein expression technologies, and the rising adoption of protein-based analytical methods. The expansion of proteomics research and the need for high-quality protein reagents in molecular biology have further propelled market demand. Additionally, the growth of personalized medicine and targeted drug development has increased the reliance on recombinant protein technologies. The emergence of AI-powered protein engineering and high-throughput screening platforms is enhancing the efficiency and scalability of protein research. As research institutions and biotech companies continue to explore novel protein-based therapeutics and diagnostics, the demand for research-grade proteins is expected to grow, shaping the future of drug discovery and biomedical innovation.

SCOPE OF STUDY

The report analyzes the Research-Grade Proteins market by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Others); Host Cell (Mammalian Cells, Bacterial Cells, Fungi & Yeast, Insect Cells, Others); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Others).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Abcam Plc; ACROBiosystems; Anaspec; Athens Research and Technology; BioLegend; Bio-Techne; BioVision, Inc.; BPS Bioscience; Cell Signaling Technology; Creative BioMart; Enzo Life Sciences; GenScript; GenWay Biotech; Lifespan Biosciences; Miltenyi Biotec; New England Biolabs; Novoprotein; OriGene Technologies; PeproTech (a Thermo Fisher brand); ProSpec-Tany Technogene Ltd.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Research-Grade Proteins – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 34 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Proliferation of Cell Biology and Molecular Research Drives Demand for High-Purity Research-Grade Proteins

Increased Investment in Cancer and Neurobiology Studies Strengthens Business Case for Recombinant Proteins

Growth in Stem Cell and Organoid Cultures Throws the Spotlight on Protein-Based Culture Supplements

Expansion of Protein-Protein Interaction Studies Accelerates Use of Tagged and Labeled Proteins

Advancements in Structural Biology and Cryo-EM Drive Demand for High-Stability Protein Constructs

Growth in Immunology and Vaccine Research Generates Demand for Purified Antigens and Cytokines

Rising Focus on Reproducibility in Life Sciences Supports Demand for cGMP-Aligned Research Reagents

Integration of AI-Based Protein Modeling Enhances Demand for Custom Engineered Proteins

Surge in Functional Proteomics Applications Supports Expansion of Signaling and Kinase Protein Libraries

Adoption of Cell-Free Protein Expression Systems Strengthens Rapid Research-Grade Protein Production

Increased Use in CRISPR and Gene Editing Workflows Fuels Market for Nucleases and Ligases

Collaborations Between Academic Labs and Biotech Firms Support Custom Protein Manufacturing

Shift Toward Serum-Free and Chemically Defined Media Expands Market for Recombinant Cell Culture Proteins

Demand for Fluorescently Labeled and Affinity-Purified Proteins Grows in Imaging and Screening Applications

Global Expansion of Bioresearch Infrastructure Enhances Access to High-Quality Protein Suppliers

Standardization of Protein Characterization Techniques Enhances Quality Benchmarks in Research Use

Rapid Growth of Biomarker Discovery and Translational Research Fuels Demand for Diagnostic-Grade Proteins

Ethical Sourcing and Elimination of Animal-Origin Products Strengthen Market for Recombinant Alternatives

Growth in Personalized Research Models Using iPSC and Patient-Derived Cells Increases Need for Specialized Proteins

Use of Research-Grade Proteins in High-Throughput Assays and Automation Platforms Propels Volume Demand

4. GLOBAL MARKET PERSPECTIVE

World Research-Grade Proteins Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Research-Grade Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Research-Grade Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Cytokines & Growth Factors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Cytokines & Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Immune Checkpoint Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Immune Checkpoint Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Virus Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Virus Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Recombinant Regulatory Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Recombinant Regulatory Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Hormones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Hormones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Bacterial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Bacterial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Fungi & Yeast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Fungi & Yeast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Insect Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Insect Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other Host Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other Host Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

JAPAN

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

CHINA

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

EUROPE

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Research-Grade Proteins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

FRANCE

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

GERMANY

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

UNITED KINGDOM

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

ASIA-PACIFIC

Research-Grade Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by Product - Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Research-Grade Proteins by Product - Percentage Breakdown of Value Sales for Cytokines & Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones and Other Products for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by Host Cell - Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Research-Grade Proteins by Host Cell - Percentage Breakdown of Value Sales for Bacterial Cells, Fungi & Yeast, Insect Cells, Other Host Cells and Mammalian Cells for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Research-Grade Proteins by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Research-Grade Proteins by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Other End-Uses for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Prolytix	%
Seramun Diagnostica GmbH	%
Tecan Trading AG	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll